Deutsche Bank Downgrades Moderna (MRNA) to Sell, 'further negative revenue revisions pressure'
Tweet Send to a Friend
(Updated - November 2, 2023 8:55 AM EDT)
Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna (NASDAQ: MRNA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna (NASDAQ: MRNA) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
